2nd Quarter - Report

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,670,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2018 $1,670,000 Replaced
2nd Quarter - Amendment Oct 19, 2018 $1,700,000 Yes

What was lobbied

11 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

S. 2098, Foreign Investment Risk Review Modernization Act of 2017. H.R. 2932, Foreign Investment and Economic Security Act of 2017. H.R. 4311, Foreign Investment Risk Review Modernization Act of 2017.

LobbyistCovered position, as disclosed
CHRISTOPHER LEAHY —
URSULA WOJCIECHOWSKI —

Contacted: Agriculture, Dept of (USDA); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Natl Security Council (NSC); Treasury, Dept of; Environmental Protection Agency (EPA); White House Office

Bills named: H.R. 2932 (115th), H.R. 4311 (115th), S. 2098 (115th)

Chemicals/Chemical Industry CHM

Monitor legislative issues and administrative action related to the chemical industry.

LobbyistCovered position, as disclosed
EDWARD J BARRON —
CHRISTOPHER LEAHY —
LUCAS TOMANELLI —

Contacted: Environmental Protection Agency (EPA); Natl Security Council (NSC); Agriculture, Dept of (USDA); White House Office; SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Trade (domestic/foreign) TRD

Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the renegotiation of the North American Free Trade Agreement (NAFTA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA).

Contacted: HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Treasury, Dept of; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); White House Office; Natl Security Council (NSC); U.S. Trade Representative (USTR); SENATE

Agriculture AGR

Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017.

Contacted: Treasury, Dept of; HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); White House Office; Natl Security Council (NSC); U.S. Trade Representative (USTR); SENATE; Environmental Protection Agency (EPA)

Bills named: H.R. 953 (115th), S. 322 (115th), H.R. 1029 (115th), H.R. 909 (115th), S. 629 (115th), S. 1528 (115th), H.R. 3040 (115th)

Taxation/Internal Revenue Code TAX

Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication.

LobbyistCovered position, as disclosed
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
JAMES P MCVANEY —
LINDSAY A. MORRIS —
PETER STEHOUWER —
URSULA WOJCIECHOWSKI —

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Treasury, Dept of; SENATE; Environmental Protection Agency (EPA); Natl Security Council (NSC); White House Office; HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Bills named: S. 85 (115th), H.R. 1 (115th), H.R. 184 (115th), H.R. 1268 (115th), H.R. 4618 (115th), S. 108 (115th), H.R. 394 (115th)

Copyright/Patent/Trademark CPT

Monitor legislative and administrative action related to intellectual property protection.

LobbyistCovered position, as disclosed
EDWARD J BARRON —
JULIE CORCORAN —
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
BRIAN NAGLE —
URSULA WOJCIECHOWSKI —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Natl Security Council (NSC); Agriculture, Dept of (USDA); SENATE; Treasury, Dept of; U.S. Trade Representative (USTR); White House Office

Health Issues HCR

Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act.

LobbyistCovered position, as disclosed
JULIE CORCORAN —
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
LINDSAY A. MORRIS —
BRIAN NAGLE —
PETER STEHOUWER —

Contacted: Environmental Protection Agency (EPA); SENATE; White House Office; Natl Security Council (NSC); Treasury, Dept of; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Bills named: H.R. 2430 (115th), H.R. 2009 (115th), S. 2434 (115th), S. 469 (115th), H.R. 3921 (115th), H.R. 3841 (115th), H.R. 2118 (115th), H.R. 2164 (115th), S. 404 (115th), H.R. 3204 (115th), S. 934 (115th), H.R. 749 (115th), H.R. 1628 (115th)

Medicare/Medicaid MMM

Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017.

LobbyistCovered position, as disclosed
JULIE CORCORAN —
CHRISTOPHER LEAHY —
LINDSAY A. MORRIS —
BRIAN NAGLE —
PETER STEHOUWER —

Contacted: Food & Drug Administration (FDA); Natl Security Council (NSC); Environmental Protection Agency (EPA); White House Office; Agriculture, Dept of (USDA); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Treasury, Dept of

Bills named: S. 260 (115th), S. 251 (115th), H.R. 849 (115th)

Budget/Appropriations BUD

Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 2810, National Defense Authorization Act for Fiscal Year 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 5515, John S. McCain National Defense Authorization Act for Fiscal Year 2019.

Contacted: White House Office; Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR); Treasury, Dept of; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Natl Security Council (NSC)

Bills named: H.R. 5515 (115th), H.R. 1625 (115th), H.R. 3268 (115th), H.R. 2810 (115th), S.Con.Res. 3 (115th), S. 1603 (115th)

Government Issues GOV

S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act.

LobbyistCovered position, as disclosed
EDWARD J BARRON —
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
JAMES P MCVANEY —
LUCAS TOMANELLI —
URSULA WOJCIECHOWSKI —

Contacted: Treasury, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Security Council (NSC); Environmental Protection Agency (EPA); White House Office; U.S. Trade Representative (USTR); SENATE; Agriculture, Dept of (USDA)

Bills named: S. 1794 (115th), S. 119 (115th), H.R. 4170 (115th), H.R. 469 (115th), S. 2039 (115th), H.R. 1430 (115th), S. 951 (115th)

Tariff (miscellaneous tariff bills) TAR

Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017.

LobbyistCovered position, as disclosed
EDWARD J BARRON —
CHRISTOPHER LEAHY —
BRIAN MCCULLOUGH —
JAMES P MCVANEY —
URSULA WOJCIECHOWSKI —

Contacted: SENATE; Environmental Protection Agency (EPA); White House Office; Natl Security Council (NSC); Treasury, Dept of; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: S. 2108 (115th), H.R. 4318 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.